Detailed histological examination was performed by measuring the NAFLD activity score (NAS), which revealed that pan PPAR-iMSC-EVs reduced inflammation, hypertrophy, and steatosis (Fig. 3F). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.